KCTD15 antibody (AA 1-234)
Quick Overview for KCTD15 antibody (AA 1-234) (ABIN528877)
Target
See all KCTD15 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-234
-
Purpose
- Mouse polyclonal antibody raised against a full-length human KCTD15 protein.
-
Sequence
- MPHRKERPSG SSLHTHGSTG TAEGGNMSRL SLTRSPVSPL AAQGIPLPAQ LTKSNAPVHI DVGSHMYTSS LATLTKYPDS RISRLFNGTE PIVLDSLKQH YFIDRDGEIF RYVLSFLRTS KLLLPDDFKD FSLLYEEARY YQLQPMVREL ERWQQEQEQR RRSRACDCLV VRVTPDLGER IALSGEKALI EEVFPETGDV MCNSVNAGWN QDPTHVIRFP LNGYCRLNSV QDVL
-
Cross-Reactivity
- Human, Rat
-
Characteristics
- Antibody reactive against mammalian transfected lysate.
-
Immunogen
- KCTD15 (NP_076981.1, 1 a.a. ~ 234 a.a) full-length human protein.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handling Advice
- Aliquot to avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Inhibition of neural crest formation by Kctd15 involves regulation of transcription factor AP-2." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Issue 8, pp. 2870-5, (2013) (PubMed).
: "The BTB-containing protein Kctd15 is SUMOylated in vivo." in: PLoS ONE, Vol. 8, Issue 9, pp. e75016, (2013) (PubMed).
-
: "Inhibition of neural crest formation by Kctd15 involves regulation of transcription factor AP-2." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Issue 8, pp. 2870-5, (2013) (PubMed).
-
- KCTD15 (Potassium Channel Tetramerisation Domain Containing 15 (KCTD15))
-
Alternative Name
- KCTD15
-
Background
-
Full Gene Name: potassium channel tetramerisation domain containing 15
Synonyms: MGC25497,MGC2628 -
Gene ID
- 79047
-
NCBI Accession
- NM_024076
Target
-